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In their recent paper evaluating arterial waveform analysis as
a tool to measure cardiac output (CO), Michael Sander and
colleagues do not provide data on the heart rhythms of their
cardiac surgery patients [1]. As the FloTrac (Flowtrac/Vigileo,
Edwards Lifescience, Munich, Germany) device calculates
CO from an arterial pressure-based algorithm, integrating
vessel compliance and peripheral resistance effects, it seems
plausible that these measurements may be influenced by
cardiac arrhythmia.
We recently treated a septic patient with atrial fibrillation who,
in addition to monitoring with the FlowTrac device, received a
pulmonary artery catheter because of a suspicion of right
ventricular failure. The patient was on pressure-controlled
mechanical ventilation. We found no significant correlation
between simultaneous measurements performed with the
pulmonary artery catheter and measurements performed with
the FlowTrac device (r = 0.297,  P = 0.405). Bland-Altman
analysis showed a mean bias of –0.43 l/min and limits of
agreement of –4.5 and 3.6 l/min (Figure 1). This finding is in
keeping with the results of a pilot study assessing the FloTrac
system, which found worse correlations between waveform-
based measurements of CO and thermodilution-derived CO
for patients with atrial fibrillation, as compared to patients
with sinus rhythm [2].
In Sanders and colleagues’ study, sinus rhythm is not
mentioned among the prerequisites for measurements to be
included in the analysis. We wonder whether the FloTrac
device could provide meaningful data in patients with regular
rhythms. Given the scarce and unfavourable data on the
validity of this system, we believe that it should not be used at
present, especially not in a medical intensive care unit setting
where supra-ventricular arrhythmia is common.
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CO = cardiac output; COPAC = pulmonary artery catheter thermodilution cardiac output; COTranspulm = transpulmonary thermodilution cardiac
output; COWave = waveform analysis cardiac output; LOA = linits of agreement.
Figure 1
Measurements of cardiac output performed with the pulmonary artery
catheter and with the FlowTrac device. Scatter plot of cardiac output
(CO) measurements by FloTrac versus measurements by pulmonary
artery catheter (PAC).Page 2 of 2
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We read with interest that Umgelter and colleagues confirmed
our data regarding the validity of the uncalibrated arterial
waveform analysis cardiac output (COWave) in a medical
intensive care unit patient. In our study we found a good
correlation of aortic transpulmonary thermodilution cardiac
output (COTranspulm) and pulmonary artery catheter
thermodilution cardiac output (COPAC) measurements prior
to, during, and after coronary artery bypass graft surgery
surgery [1]. We found an overall mean bias and a limit opf
agreement (LOA) of –0.1 l/min and from –1.8 to +1.6 l/min,
respectively, for COPAC versus COTranspulm. In contrast to this
we could not establish that pulse contour analysis with an
uncalibrated pulse contour algorithm (COWave) is a method
yielding reliable results under difficult conditions in
perioperative coronary artery bypass graft patients. COWave
underestimated COPAC and showed a wide range of LOAs
[1]. In the study we observed a mean bias and a LOA of 0.6
l/min and from –2.2 to +3.4 l/min, respectively, for COPAC
versus COWave.
We agree with Umgelter and colleagues that the cardiac
rhythm might influence the algorithm by which the COWave
device calculates the CO. The influence of the heart rhythm
on the validity of pulse contour CO devices is unclear,
however, as no good controlled studies have so far been
published. At least we can state that, in our study, this was
not the reason for the underestimation of and the wide range
of LOAs, since during the study all patients had sinus rhythm
at all measurement points. Even for calibrated pulse contour
systems it is not entirely clear when recalibration is necessary
[3-6]. Proving the validity of uncalibrated devices is therefore
even more important in large controlled clinical trials in
patients with different clinical problems such as unstable
heart rhythms, changes in systemic vascular resistance, and
haemorrhagic shock.
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